Trasferrin receptor 2 gene regulation by microRNA 221 in SH-SY5Y cells treated with MPP+ as Parkinson's disease cellular model

Neuroscience Research

Volumn 77, Issue 3, 2013, Pages 121-127

  Asci, Roberta ^a,b   Vallefuoco, Fara ^a,b   Andolfo, Immacolata ^a,b   Bruno, Mariasole ^a,b   De Falco, Luigia ^a,b   Iolascon, Achille ^a,b  

^a CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Iron metabolism; MicroRNA 221; Parkinson's disease; TfR2

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; LUCIFERASE; MICRORNA 221; TRANSFERRIN RECEPTOR 2;

ARTICLE; CELL LINE; CONTROLLED STUDY; GENE CONTROL; GENE OVEREXPRESSION; HUMAN; IN VITRO STUDY; IRON TRANSPORT; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM;

IRON METABOLISM; MICRORNA-221; PARKINSON'S DISEASE; TFR2;

CELL LINE, TUMOR; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; MPTP POISONING; RECEPTORS, TRANSFERRIN;

EID: 84886586207     PISSN: 01680102     EISSN: 18728111     Source Type: Journal    
DOI: 10.1016/j.neures.2013.09.003     Document Type: Article

References (32)

1. Andolfo I., De Falco L., Asci R., Russo R., Colucci S. Regulation of divalent metal transporter 1 (DMT1) non-IRE isoform by the microRNA Let-7d in erythroid cells. Haematologica 2010, 95:1244-1252.
2. Andrews N.C. Forging a field: the golden age of iron biology. Blood 2008, 112:219-230.
3. Baltimore D., Boldin M.P., O'Connell R.M., Rao D.S., Taganov K.D. MicroRNAs: new regulators of immune cell development and function. Nat. Immunol. 2008, 9:839-845.
4. Baskerville S., Bartel D.P. Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA 2005, 11:241-247.
5. Ben-Shachar D., Eshel G., Finberg J.P., Youdim M.B., et al. The iron chelator desferrioxamine (Desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons. J. Neurochem. 1991, 56:1441-1444.
6. Berg D., Hochstrasser H. Iron metabolism in parkinsonian syndromes. Mov. Disord. 2006, 21:1299-1310.
7. Borie C., Gasparini F., Verpillat P., et al. Association study between iron-related genes polymorphisms and Parkinson's disease. J. Neurol. 2002, 249:801-804.
8. Connor J.R., Fine R.E. The distribution of transferrin immunoreactivity in the rat central nervous system. Brain Res. 1986, 368:319-328.
9. De Domenico I., McVey Ward D., Kaplam J. Regulation of iron acquisition and storage: consequences for iron-linked disorders. Nat. Rev. Mol. Cell Biol. 2008, 9:72-81.
10. Dexter D.T., Wells F.R., Agid F., et al. Increased nigral iron content in postmortem parkinsonian brain. Lancet 1987, 2:1219-1220.
11. Gałazka-Friedman J., Bauminger E.R., Friedman A., et al. Iron in parkinsonian and control substantia nigra-a Mössbauer spectroscopy study. Mov. Disord. 1996, 11:8-16.
12. Götz M.E., Double K., Gerlach M., Youdim M.B., Riederer P. The relevance of iron in the pathogenesis of Parkinson's disease. Ann. N.Y. Acad. Sci. 2004, 1012:193-208.
13. Guerreiro R.J., Bras J.M., Santana I., et al. Association of HFE common mutations with Parkinson's disease, Alzheimer's disease and mild cognitive impairment in a Portuguese cohort. BMC Neurol. 2006, 6:24.
14. Halliday G.M., Del Tredici K., Braak H. Critical appraisal of brain pathology staging related to presymptomatic and symptomatic cases of sporadic Parkinson's disease. Neural. Transm. Suppl. 2006, 70:S99-S103.
15. Hentze M.W., Argos P. Homology between IRE-BP, a regulatory RNA-binding protein, aconitase, and isopropylmalate isomerase. Nucleic Acids Res. 1991, 19:1739-1740.
16. Hirsch E.C. Iron transport in Parkinson's disease. Parkinsonism Relat. Disord. 2009, 15S3:S209-S211.
17. Hirsch E.C., Brandel J.P., Galle P., Javoy-Agid F., Agid Y. Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis. J. Neurochem. 1991, 56:446-451.
18. Iversen S.D., Iversen L.L. Dopamine: 50 years in perspective. Trends Neurosci. 2007, 30:188-193.
19. Kaur D., Peng J., Chinta S.J., et al. Increased murine neonatal iron intake results in Parkinson-like neurodegeneration with age. Neurobiol. Aging 2006, 28:907-913.
20. Kawabata H., Yang R., Hirama T., et al. Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family. J. Biol. Chem. 1999, 274:20826-20832.
21. Kim S.Y., Woo M.S., Park J.S., Hyun J.W., Kim Y.S., et al. The neuroprotective role of tissue inhibitor of metalloproteinase-2 in MPP+- or 6-OHDA-treated SK-N-BE(2)C and SH-SY5Y human neuroblastoma cells. Neurosci. Lett. 2010, 468:136-140.
22. Lei P., Ayton S., Finkelstein D.I., Spoerri L., Ciccotosto G.D., et al. Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export. Nat. Med. 2012, 18:291-295.
23. Lesage S., Brice A. Parkinson's disease: from monogenic forms to genetic susceptibility factors. Hum. Mol. Genet. 2009, 18(R1):R48-R59.
24. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(DeltaDelta C(T)). Method Methods 2001, 25:402-408.
25. Lok C.N., Ponka P. Identification of a hypoxia response element in the transferrin receptor gene. J. Biol. Chem. 1999, 274:24147-24152.
26. Mastroberardino P.G., Hoffman E.K., Horowitz M.P., Betarbet R., Taylor G., et al. A novel transferrin/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson's disease. Neurobiol. Dis. 2009, 34:417-431.
27. Schapira A.H. Neurobiology and treatment of Parkinson's disease. Trends Pharmacol. Sci. 2009, 30:41-47.
28. Sian-Hülsmann J., Mandel S., Youdim M.B., Riederer P. The relevance of iron in the pathogenesis of Parkinson's disease. J. Neurochem. 2011, 118:939-957.
29. Sofic E., Riederer P., Heinsen H., et al. Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain. J. Neural Transm. 1988, 74:199-205.
30. Theil E.C., Eisenstein R.S. Combinatorial mRNA regulation: iron regulatory proteins and iso-iron-responsive elements (Iso-IREs). J. Biol. Chem. 2000, 275:40659-40662.
31. Williams A.E. Functional aspects of animal microRNAs. Cell. Mol. Life Sci. 2008, 65:545-562.
32. Zheng W., Monnot A.D. Regulation of brain iron and copper homeostasis by brain barrier systems: implication in neurodegenerative diseases. Pharmacol. Ther. 2012, 133:177-188.